Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2005
The objective of this study is to determine if the safety and tolerability of Immune Globulin Intravenous (Human), 10% caprylate/chromatography (IGIV-C)purified is similar when infused at two different infusion rates. The primary objective is to compare the incidence and severity of all infusion related adverse events when IGIV-C, 10% is administered at a rate of 0.14 mL/kg/min compared to a rate of 0.08 mL/kg/min after a single daily infusion.
Epistemonikos ID: 6a72056b5ced12f3e68e0d0ed6b7bfd5d362d900
First added on: Dec 01, 2021